financetom
Market
financetom
/
Market
/
Jio Financial Services clarifies on news reports of raising funds via bonds, says no such plans
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jio Financial Services clarifies on news reports of raising funds via bonds, says no such plans
Nov 21, 2023 6:50 AM

Jio Financial Services, which was carved out of Reliance Industries, currently has no plans to raise money by way of bond issuance or otherwise, the company said in a regulatory filing on Tuesday, November 21.

Share Market Live

NSE

"We wish to clarify that currently, the company has no plans to raise money by way of bond issuance or otherwise. The news item is speculative," it said in a statement.

Jio Financial was said to be in early talks with merchant bankers for its maiden bond issue, according to a Reuters report.

The report, citing four sources, said the company may look to raise ₹5,000 crore to ₹10,000 crore through the issue and may tap the market in the last quarter of this financial year.

Jio Financial was in the process of getting approvals and a credit rating, the report added.

Mukesh Ambani’s financial services venture plans to establish itself as a full-service financial services firm in a rapidly growing market, including auto, home loans and other products, competing with the likes of Bajaj Finance.

The company has doubled its net profit during the second quarter this financial year (Q2FY24) to ₹668 crore from ₹331.92 crore in Q1FY24, led by healthy growth in revenue.

Jio Financial Services was listed at ₹265 on the BSE and ₹262 on the NSE in August 2023. The stock settled 2.02% higher at ₹219.85 apiece today. The scrip has gained 6.41% in the last one month.

First Published:Nov 21, 2023 3:50 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Equity Indexes Rise as Technology Surges Following Salesforce Results While ISM Services Dives More Than Forecast
US Equity Indexes Rise as Technology Surges Following Salesforce Results While ISM Services Dives More Than Forecast
Dec 4, 2024
12:12 PM EST, 12/04/2024 (MT Newswires) -- US equity indexes rose amid gains in the technology sector and ahead of comments from Federal Reserve Chair Jerome Powell after a services index corroborated a slowdown in expansion. The S&P 500 climbed 0.4% to 6,075.8 after midday on Wednesday, after touching a new intraday record high earlier in the session. The Nasdaq...
US STOCKS-Tech surge propels S&P 500, Nasdaq to all-time highs; Powell comments in focus
US STOCKS-Tech surge propels S&P 500, Nasdaq to all-time highs; Powell comments in focus
Dec 4, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Salesforce ( CRM ) jumps after beating Q3 revenue estimates * November ADP private payrolls at 146,000 versus 150,000 estimate * ISM non-manufacturing PMI at 52.1 in November, below estimates * Indexes up: Dow 0.53%, S&P 500 0.37%, Nasdaq...
Top Midday Stories: UnitedHealthcare CEO Fatally Shot in Manhattan; Salesforce Tops Q3 Revenue Expectations
Top Midday Stories: UnitedHealthcare CEO Fatally Shot in Manhattan; Salesforce Tops Q3 Revenue Expectations
Dec 4, 2024
11:49 AM EST, 12/04/2024 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Wednesday, with the Nasdaq Composite leading the ascent thanks to some strong earnings reports from tech companies. In company news, UnitedHealth Group's ( UNH ) UnitedHealthcare Chief Executive Brian Thompson was fatally shot Wednesday morning in Midtown Manhattan in what New York...
Stock Of The Day: Where Will The Eli Lilly Rally End?
Stock Of The Day: Where Will The Eli Lilly Rally End?
Dec 4, 2024
Shares of Eli Lilly and Company ( LLY ) are trading higher on Wednesday. The company said that its Zepbound drug was more effective in helping adults with obesity lose weight than Novo Nordisk A/S's ( NVO ) Wegovy. It cited data from a phase 3b trial. But the rally may be short-lived. This is why Eli Lilly ( LLY )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved